IRAK4 and Autoimmunity: Among all the nucleic acid-modifying enzymes, inhibitors targeting kinases have been developed for the treatment of autoimmunity and inflammation, including JAK, IRAK4, RIPK, SYK, BTK, and TPL2 (180).